Iodination of salicylic acid improves its binding to transthyretin.

Article Details

Citation

Copy to clipboard

Gales L, Almeida MR, Arsequell G, Valencia G, Saraiva MJ, Damas AM

Iodination of salicylic acid improves its binding to transthyretin.

Biochim Biophys Acta. 2008 Mar;1784(3):512-7. Epub 2007 Dec 3.

PubMed ID

18155178 [ View in PubMed

]

Abstract

Transthyretin (TTR) is a plasma homotetrameric protein associated with senile systemic amyloidosis and familial amyloidotic polyneuropathy. In theses cases, TTR dissociation and misfolding induces the formation of amyloidogenic intermediates that assemble into toxic oligomeric species and lead to the formation of fibrils present in amyloid deposits. The four TTR monomers associate around a central hydrophobic channel where two thyroxine molecules can bind simultaneously. In each thyroxine binding site there are three pairs of symmetry related halogen binding pockets which can accommodate the four iodine substituents of thyroxine. A number of structurally diverse small molecules that bind to the TTR channel increasing the protein stability and thereafter inhibiting amyloid fibrillogenesis have been tested. In order to take advantage of the high propensity to interactions between iodine substituents and the TTR channel we have identified two iodinated derivatives of salicylic acid, 5-iodosalicylic acid and 3,5-diiodosalicylic acid, available commercially. We report in this paper the relative binding affinities of salicylic acid and the two iodinated derivatives and the crystal structure of TTR complexed with 3,5-diiodosalicylic acid, to elucidate the higher binding affinity of this compound towards TTR.

DrugBank Data that Cites this Article

Drug Carriers

Drug	Carrier	Kind	Organism	Pharmacological Action	Actions
2-HYDROXY-3,5-DIIODOBENZOIC ACID	Transthyretin	Protein	Humans	Unknown	Not Available	Details

Polypeptides

Name	UniProt ID
Transthyretin	P02766	Details